SEC 13F Intelligence

Skandinaviska Enskilda Banken AB (Publ) / TMO

Skandinaviska Enskilda Banken AB (Publ)’s Thermo Fisher Scientific Inc Position

Does Skandinaviska Enskilda Banken AB (Publ) own Thermo Fisher Scientific Inc (TMO)? Yes — 112.0K shares worth $55M (+1.27% of its 13F portfolio) as of Q1 2026, down from 249.6K shares the prior filed quarter.

Position Value
$55M
Q1 2026
Shares
112.0K
% of Portfolio
+1.27%
Quarters Held
30
currently held

Position History TMO

Reported value by quarter
Q4 ’18: $17MQ4 ’18Q1 ’19: $21MQ2 ’19: $24MQ3 ’19: $39MQ4 ’19: $44MQ4 ’19Q1 ’20: $36MQ2 ’20: $53MQ3 ’20: $67MQ4 ’20: $80MQ4 ’20Q1 ’21: $111MQ2 ’21: $100MQ3 ’21: $110MQ4 ’21: $117MQ4 ’21Q1 ’22: $95MQ2 ’22: $85MQ3 ’22: $112MQ4 ’22: $78,592Q4 ’22Q1 ’23: $80,476Q2 ’23: $71,408Q3 ’23: $73,899Q4 ’23: $70MQ4 ’23Q1 ’24: $109MQ2 ’24: $98MQ3 ’24: $109MQ4 ’24: $91MQ4 ’24Q1 ’25: $118MQ2 ’25: $88MQ3 ’25: $135MQ4 ’25: $145MQ4 ’25Q1 ’26: $55Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026112.0K$55M+1.27%
Q4 2025249.6K$145M+0.58%
Q3 2025279.4K$135M+0.54%
Q2 2025216.1K$88M+0.38%
Q1 2025236.9K$118M+0.58%
Q4 2024174.6K$91M+0.41%
Q3 2024175.8K$109M+0.50%
Q2 2024176.7K$98M+0.47%
Q1 2024188.2K$109M+0.54%
Q4 2023131.1K$70M+0.40%
Q3 2023146.0K$73,899+0.48%
Q2 2023136.9K$71,408+0.47%
Q1 2023139.6K$80,476+0.56%
Q4 2022142.7K$78,592+0.59%
Q3 2022221.7K$112M+0.87%
Q2 2022156.8K$85M+0.63%
Q1 2022160.8K$95M+0.56%
Q4 2021175.9K$117M+0.60%
Q3 2021192.1K$110M+0.60%
Q2 2021197.5K$100M+0.61%
Q1 2021243.0K$111M+0.73%
Q4 2020172.5K$80M+0.55%
Q3 2020152.5K$67M+0.49%
Q2 2020145.7K$53M+0.43%
Q1 2020127.0K$36M+0.38%
Q4 2019135.9K$44M+0.35%
Q3 2019133.5K$39M+0.33%
Q2 201982.1K$24M+0.21%
Q1 201976.1K$21M+0.19%
Q4 201874.8K$17M+0.15%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Skandinaviska Enskilda Banken AB (Publ)’s full portfolio or all institutional holders of TMO.